carbon monoxide has been researched along with Skin Neoplasms in 5 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Skin Neoplasms: Tumors or cancer of the SKIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| WYNDER, EL | 1 |
| HOFFMANN, D | 1 |
| Allanson, M | 1 |
| Reeve, VE | 1 |
| Denton, AS | 1 |
| Simpson, JK | 1 |
| Hallam, M | 1 |
| Spittle, MF | 1 |
| Miller, RF | 1 |
| Gaworski, CL | 1 |
| Heck, JD | 1 |
| Bennett, MB | 1 |
| Wenk, ML | 1 |
| Ireland-Gill, A | 1 |
| Espina, BM | 1 |
| Akil, B | 1 |
| Gill, PS | 1 |
5 other studies available for carbon monoxide and Skin Neoplasms
| Article | Year |
|---|---|
REDUCTION OF TUMORIGENICITY OF CIGARETTE SMOKE: AN EXPERIMENTAL APPROACH.
Topics: Aldehydes; Animals; Benzopyrenes; Carbon Monoxide; Carcinogens; Cilia; Formates; Lung Diseases; Lung | 1965 |
Carbon monoxide signalling reduces photocarcinogenesis in the hairless mouse.
Topics: Animals; Carbon Monoxide; Carcinogens; Disease Progression; Down-Regulation; Female; Heme Oxygenase- | 2007 |
Effects on pulmonary function of two regimens of chemotherapy for AIDS related Kaposi's sarcoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antineoplastic Agents, Ph | 1996 |
Toxicologic evaluation of flavor ingredients added to cigarette tobacco: skin painting bioassay of cigarette smoke condensate in SENCAR mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Biological Assay; Body Weight; C | 1999 |
Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma using bleomycin-containing combination chemotherapy regimens.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 1992 |